What Is GEHC Fair Value?
GE HealthCare (GEHC) fair value estimate using multiple valuation models, updated daily.
As of August 29, 2026, GE HealthCare (GEHC) has a composite fair value estimate of $57.28 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $71.73, suggesting the stock is overvalued by 20.1%.
Data as of August 29, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$57.28
vs. current price of $71.73(-20.1%)
How Is GEHC Fair Value Calculated?
Four independent models estimate what GEHC is worth. Each uses different inputs and assumptions. The composite blends them by weight.
GEHC Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$76.56
+6.7%Fair Value
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$3.10
-95.7%Overvalued
Inputs used
GEHC Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$51.90
-27.6%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$49.27
-31.3%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $71.72 is 6.7% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.71B | $1.58B |
| Year 2 | $1.85B | $1.60B |
| Year 3 | $2.01B | $1.61B |
| Year 4 | $2.19B | $1.62B |
| Year 5 | $2.37B | $1.63B |
| Year 6 | $2.58B | $1.65B |
| Year 7 | $2.80B | $1.66B |
| Year 8 | $3.04B | $1.67B |
| Year 9 | $3.30B | $1.68B |
| Year 10 | $3.58B | $1.70B |
| Terminal Value | $69.77B | $33.04B |
What Are GEHC's Key Financial Metrics?
Earnings & Growth
Current Price
$71.73
EPS (TTM)
$4.30
Forward P/E
13.3
Profit Margin
9.3%
Cash & Balance Sheet
Free Cash Flow
1.6B
EBITDA
3.6B
Book Value
$24.30
Total Debt
10.5B
What Do Analysts Say About GEHC?
Low
$70.00
Average
$82.50
High
$96.00
Upside
+15.0%
GEHC Fair Value FAQ
What is the fair value of GEHC?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), GEHC's estimated fair value is $57.28. The stock is currently trading at $71.73, which makes it overvalued by our analysis.
How is GEHC's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is GEHC overvalued or undervalued?
Based on our analysis, GEHC is overvalued. The current price of $71.73 is 20.1% above our estimated fair value of $57.28.
What do Wall Street analysts say about GEHC?
18 analysts cover GE HealthCare with a consensus rating of "Buy." The average price target is $82.50, ranging from $70.00 to $96.00. This implies 15.0% upside from the current price.